Open access
1,029
Views
0
CrossRef citations to date
0
Altmetric
Letter
Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)
Ulrike K. Buchwalda CR, Merck & Co., Inc, Upper Gwynedd, PA, USA
, Temitope Folaranmib GMA, Merck & Co., Inc.,Upper Gwynedd, PA, USA
& Thomas Weissc CORE, Merck & Co., Inc.,Upper Gwynedd, PA, USACorrespondence[email protected]
Pages 173-175
|
Received 20 Dec 2019, Accepted 29 Feb 2020, Published online: 02 Jul 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.